Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Post by FredTheVoiceon Mar 09, 2018 3:54pm

216 Views

Post# 27694123

10$ ?

At this point. With all that is expressed and shared on this board. With the reality of the great job THERA is doing right now. ....Selling under 15$ is pretty stupid.
But we all have our price in mind. And our life contingencies.
10$ is not a celebration for me. Approval was. And all the next steps will be.

But I confess ! Im very happy the way the stock ruled this week !

Best is coming. I Believe.

FTV.

Bullboard Posts

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta